Maynard Um
-
-
-
-
-
-
-
Revolution (RVMD) Reiterated at Buy by Stifel
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Revolution (RVMD)
-
-
-
-
-
-
-
Revolution (RVMD) PT Raised to $162 at RBC Capital
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Revolution (RVMD)
-
-
-
-
-
-
-
Revolution (RVMD) PT Raised to $120 at Piper Sandler
-
-
-
-
-
-
-
Revolution Medicines stock falls after Merck reportedly ends acquisition pursuit
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on Revolution (RVMD)
-
404,872 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

